A5034336301- Long-Term Effects of COVID-19
- Liver Diseases and Immunity
- SARS-CoV-2 and COVID-19 Research
- Liver Disease Diagnosis and Treatment
- COVID-19 Clinical Research Studies
- Pediatric Hepatobiliary Diseases and Treatments
Centre Hospitalier Universitaire Hassan II
2021
Sidi Mohamed Ben Abdellah University
2021
Background: Coronavirus disease 2019 (COVID-19) has emerged as a global human health threat. While SARS-CoV-2 infection exhibits fever and respiratory symptoms, extrarespiratory manifestations were also reported in many cases. Objectives: This study aimed to determine the prevalence of digestive hepatic symptoms at onset assess whether are associated with severe progression. Patients Methods: Prospective was conducted during first COVID-19 wave (from April October 2020). It included...
Introduction: Primary biliary cholangitis (PBC), the new dominance of primary cirrhosis, is a cholestatic disease autoimmune etiology and represents leading cause intra-hepatic cholestasis. Treatment mainly based on ursodeoxycholic acid. The biological response to treatment main predictor survival without liver transplantation. Globe-score has been recently validated as prognostic factor. Materials methods: This retrospective study carried out in our department collating all cases PBC...